Evidence map›Paper›PMID 40707226›Full record

ArticleInternal medicine (Tokyo, Japan)2026

Extraparenchymal Brain Lesions in Anti-NMDAR Encephalitis Leading to Primary Leptomeningeal Lymphoma: A Rare Evolution with Diagnostic Implications.

Yuriko Aratake, Hitoshi Mori, Naoki Okada, Yoko Akaike, Katsuro Shindo

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuriko AratakeDepartment of Neurology, Kyoto University Graduate School of Medicine, Japan.
Hitoshi MoriDepartment of Internal medicine, Kawasaki Medical School General Medical Center, Japan.
Naoki OkadaDepartment of Hematology, Kurashiki Central Hospital, Japan.
Yoko AkaikeDepartment of Pathology, Kurashiki Central Hospital, Japan.
Katsuro ShindoDepartment of Neurology, Kurashiki Central Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-N-methyl-d-aspartate receptor encephalitis is an autoimmune disorder typically associated with normal or intraparenchymal brain magnetic resonance imaging (MRI) findings. We herein report a patient who initially presented with extraparenchymal brain lesions and later developed primary leptomeningeal lymphoma (PLML), an uncommon sequence that may inform clinical vigilance and diagnostic refinement. A 49-year-old woman presented with a headache and dysarthria. MRI revealed hyperintensity along the right central sulcus and fluid accumulation in the right frontal epidural space. Anti-NMDAR antibodies were detected in the cerebrospinal fluid, confirming the diagnosis of anti-NMDAR encephalitis. She was treated with steroids, intravenous immunoglobulin, plasma exchange, and cyclophosphamide, which resulted in a full recovery. Two years later, she presented with cerebellar symptoms and was diagnosed with PLML via a brain biopsy. Atypical extraparenchymal brain lesions were present at disease onset. Despite successful initial treatment, the patient later developed PLML, suggesting a potential paraneoplastic relationship or immunological continuum between the two diseases. his case illustrates the diagnostic challenges posed by atypical neuroimaging findings in anti-NMDAR encephalitis and the need for a longitudinal follow-up. Clinicians should consider neoplastic etiologies when imaging or the clinical course deviates from the norm, even if anti-NMDAR antibodies are positive.

Indexed as

Anti-N-Methyl-D-Aspartate Receptor EncephalitisBrainLymphomaMeningeal NeoplasmsFemaleHumansMagnetic Resonance ImagingMaleMiddle Agedanti-NMDAR encephalitisprimary leptomeningeal lymphoma

Identifiers

PMID40707226
PMCPMC12979772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.